Max is the founder and CEO of Science Corporation and previously co-founded Neuralink.
Press
Science CorporationMax Hodak | Science CorporationScience Corporation is a clinical-stage medical technology company.
maxhodak_Max HodakPersonal site supporting San Francisco location, biomedical engineering training, current CEO role at Science, Neuralink President role through early 2021, Transcriptic CEO role, and Duke graduation.
Reality engineer. maxhodak has 35 repositories available. Follow their code on GitHub.
X (formerly Twitter)Max Hodak (@maxhodak_) on Xbetter living through technology
Science CorporationScience Founder and CEO Max Hodak Named to Time 100 Health List of the World’s Most Influential Leaders in Health | Science CorporationScience Corporation is a clinical-stage medical technology company.
Science CorporationScience Closes $230 Million Series C to Fund Commercialization of PRIMA BCI Retinal Implant and Expansion of Clinical Trials | Science CorporationScience Corporation is a clinical-stage medical technology company.
Business WireMotif Neurotech Raises $18.75 Million in Series A FinancingSupports Motif Neurotech description, financing round, and Max Hodak as an individual investor.
- Previous roleFounder and CEO, Transcriptic
- Previous roleBiomedical engineering, Duke
- 2021-04 – PresentScience CorporationFounder and CEO
- Since 2012TranscripticCo-founder and CEO
- Until 2012-05Duke University Pratt School of EngineeringBiomedical engineering; BCI research in the Nicolelis Lab
- NeurotechnologyMotif NeurotechNeurotechnology company developing minimally invasive brain interfaces.
Max has spent his career in neural engineering, BCI research, and biotechnology company building.